This is a synthetic peptide designed for use in combination with anti-MAPKAPK2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
MAPKAPK2
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
MAPKAP Kinase 2 (MAPKAPK2)
(Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2))
Hintergrund
MAPKAPK2 is a member of the Ser/Thr protein kinase family. This kinase is regulated through direct phosphorylation by p38 MAP kinase. In conjunction with p38 MAP kinase, this kinase is known to be involved in many cellular processes including stress and inflammatory responses, nuclear export, gene expression regulation and cell proliferation. Heat shock protein HSP27 was shown to be one of the substrates of this kinase in vivo.
Alias Symbols: 3PK, MAPKAP3, MK2, MK-2, MAPKAP-K2
Protein Interaction Partner: HNRNPA0,MDM2,ARPC5,MDM2,YWHAZ,YWHAZ,AKT1,ALOX5,ARPC5,BAG2,CREB1,EEF2K,ETV1,HNRNPA0,HSF1,HSPB1,LSP1,MAPK14,MAPKAPK2,PHC2,SHC1,SRF,TCF3,TH,TSC2,YWHAZ,ZFP36,AKT1,CDC25B,EGF,ETV1,HSPB1,HSPB1,MAPK1,MAPK14,PHC2,SHC1,Tsc2